mProX™ Human P2RY12 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- GPCR Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Ava
Verified Customer
Ethan
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Laser injury does not influence capillary perfusion; instead, it causes an accumulation of juxtavascular microglia processes.
Focused laser injury location in the cerebral cortex of CX3CR1+/EGFP rats was analyzed using immunohistochemistry. P2RY12 and E-cadherin, which are both strongly expressed in the microglial cell processes around the damage site, colocalized with EGFP (green). Occludin (red), in contrast, was exclusively found in vascular endothelial cells and not in microglial cells.
Ref: Lou, Nanhong, et al. "Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier." Proceedings of the National Academy of Sciences 113.4 (2016): 1074-1079.
Pubmed: 26755608
DOI: 10.1073/pnas.1520398113
Research Highlights
Immune brain cells called microglia play a role in neuroinflammation. Numerous proteins, including receptors that can be activated by mediators secreted in the microglial milieu, are expressed on their surface. Purinergic receptor expression could change in relation to the activation level of microglia among these receptors.
Gómez Morillas, Albert, Valérie C. Besson, and Dominique Lerouet. "Microglia and neuroinflammation: what place for P2RY12?." International journal of molecular sciences 22.4 (2021): 1636.
Pubmed:
33561958
DOI:
10.3390/ijms22041636
Following cerebrovascular injury, microglial cells have a hitherto unappreciated protective role in maintaining BBB integrity. Clopidogrel is frequently prescribed to individuals with coronary artery and cerebrovascular disease because it inhibits the platelet P2Y12 receptor.
Lou, Nanhong, et al. "Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier." Proceedings of the National Academy of Sciences 113.4 (2016): 1074-1079.
Pubmed:
26755608
DOI:
10.1073/pnas.1520398113